Article Type

16 - 30 of 120 Results       Clear All

Covid Was Vanishing Last Memorial Day. Cases Are Five Times Higher Now.

Gladstone in the News May 28, 2022

Covid Was Vanishing Last Memorial Day. Cases Are Five Times Higher Now.

Washington Post—Even as COVID restrictions are easing, case numbers are rising around the country. Melanie Ott, director of the Gladstone Institute of Virology, explains that recent research from her group shows that individuals infected with the Omicron variant have limited natural immunity, and may still be susceptible to infection with Omicron subvariants.

Gladstone Experts COVID-19 Virology Ott Lab

Scientists Explain Why Getting Infected With Omicron Doesn’t Protect You From Other COVID Variants

Gladstone in the News May 20, 2022

Scientists Explain Why Getting Infected With Omicron Doesn’t Protect You From Other COVID Variants

ABC News—Gladstone virologists investigated the effect of the Omicron variant on the immune response. Melanie Ott describes her team’s discovery that previous infection with Omicron does not result in strong immunity to other known SARS-CoV-2 variants. However, as Nadia Roan explains, individuals who were vaccinated before becoming infected with Omicron did have a broadly protective immune response, emphasizing the importance of the vaccines in saving lives.

Gladstone Experts COVID-19 Virology Doudna Lab Greene Lab Ott Lab Roan Lab

It’s Happening Again: COVID-19 Cases Are Back on the Rise. There Are 3 Main Reasons Why.

Gladstone in the News May 18, 2022

It’s Happening Again: COVID-19 Cases Are Back on the Rise. There Are 3 Main Reasons Why.

USA Today—When the Omicron variant of SARS-CoV-2 swept the country this winter, many had hoped it might help move the population closer to herd immunity. However, Director of the Gladstone Institute of Virology Melanie Ott describes her team’s research that shows that previous infection with Omicron does not provide strong protection against infection with other variants.

Gladstone Experts COVID-19 Virology Ott Lab

What the Current Spike in Covid-19 Cases Could Say About the Coronavirus’ Future

Gladstone in the News May 12, 2022

What the Current Spike in Covid-19 Cases Could Say About the Coronavirus’ Future

STAT News—COVID-19 case numbers are rising once again across the United States. Melanie Ott, director of the Gladstone Institute of Virology, explains that the virus is adapting to a new immune landscape, with variants emerging that are able to cause infection even in individuals who were previously infected.

Gladstone Experts COVID-19 Virology Ott Lab

Do You Need a 4th Dose of a COVID-19 Vaccine? There’s No One-Size-Fits-All Answer

Gladstone in the News March 30, 2022

Do You Need a 4th Dose of a COVID-19 Vaccine? There’s No One-Size-Fits-All Answer

CBC—The FDA recently authorized a fourth dose of the Pfizer-BioNTech COVID-19 vaccine for all individuals over aged 50, and for those 12 and older with immunodeficiencies. Melanie Ott, director of the Gladstone Institute of Virology, explains that whereas a fourth shot may not be urgently necessary for individuals who are young and healthy, she does encourage those eligible to ensure that they get their third shot (first booster).

Gladstone Experts COVID-19 Virology Ott Lab

Three Ways to Strengthen a Collaborative Culture

Gladstone in the News March 9, 2022

Three Ways to Strengthen a Collaborative Culture

The APQC Blog—Gladstone President Deepak Srivastava, MD, President Emeritus Robert Mahley, MD, PhD, Senior Investigators Melanie Ott, MD, PhD, and Katie Pollard, PhD, explain how they and others at Gladstone create a collaborative research culture and plan to balance safety with the chance encounters that fuel creativity.

Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Virology Huang Lab Ott Lab Pollard Lab Srivastava Lab Weinberger Lab

Disease in a Dish: What Mini-Hearts and Other Organs Reveal about Long COVID

Gladstone in the News March 9, 2022

Disease in a Dish: What Mini-Hearts and Other Organs Reveal about Long COVID

San Jose Mercury News—Senior Investigators Melanie Ott, MD, PhD, and Bruce Conklin, MD, recount how they used miniature balls of beating heart cells called organoids to study the effects of COVID-19 on the heart. The heart cells were derived from a person's skin cells, thanks to technology pioneered by Senior Investigator and Nobel Laureate Shinya Yamanaka, MD, PhD.

Gladstone Experts Stem Cell Core COVID-19 Cardiovascular Disease Data Science and Biotechnology Virology Conklin Lab Ott Lab Yamanaka Lab Organoids

More News

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media